The MEngSc (Pharmaceutical and Biopharmaceutical Engineering) is a part-time programme running for a minimum of 24 months (maximum 60 months) from the date of first registration for the programme.

In Part I students take modules to the value of 60 credits. Taught modules will be offered on a cyclical basis as detailed below.
Part II consists of a Dissertation to the value of 30 credits. The choice of modules is subject to the approval of the Programme Director.

Students take 90 credits as follows:

Part I
Students take 60 credits from the following:

Offered in 2021/22
PE6004 Biopharmaceutical Support Systems (5 credits)
PE6010 Pharmaceutical Engineering (5 credits)
PE6011 Biopharmaceutical Engineering (5 credits)
PE6012 Pharmaceutical Process Equipment, Materials and Mechanical Design (5 credits)
PE6013 Powder and Particle Technology and Unit Operations (5 credits)
PE6019 Process Analytical Technology (5 credits)
PE6023 Pharmaceutical and Biopharmaceutical Utilities (5 credits)
PE6027 Advanced Biopharmaceutical Engineering (5 credits)

Offered in 2022/23
CM6010 Introductory Pharmaceutical Chemistry (5 credits)
PE6016 Pharmaceutical Industry; Manufacturing and Optimisation (5 credits)
PE6018 Pharmaceutical Process Validation and Quality (5 credits)
PE6022 Aseptic Manufacturing Design (5 credits)
PE6024 Advanced Process Design & Safety Engineering (5 credits)
PE6025 Advanced Health and Safety Management (5 credits)
PE6026 Project Engineering - From Concept to Completion (5 credits)
PF6302 Introduction to Pharmaceutics: Formulation Science (5 credits)

Module Semester Information may be found here. Module Descriptions may be found here.

Part II
PE6021 Dissertation in Pharmaceutical and Biopharmaceutical Engineering (30 credits)

Examinations
Full details and regulations governing Examinations for each programme will be contained in the Marks and Standards 2021/2022 Book and for each module in the Book of Modules, 2021/2022.

Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering
Students who pass all modules in Part I but fail to achieve the requisite grade of 50% across the taught modules will be eligible for the award of a Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering. A candidate who passes Part I of the programme and who does not wish to proceed to Part II, may opt to be conferred with a Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering.

Individual Modules
Candidates who satisfy the programme eligibility criteria may, subject to the approval of the Programme Coordinator, be permitted to take individual modules, as part of UCC's commitment to Continuing Professional Development (CPD), and be provided with a relevant transcript of marks.

Programme Learning Outcomes for MEngSc in Pharmaceutical and Biopharmaceutical Engineering (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:

• Apply an enhanced knowledge and understanding of the mathematics, sciences, engineering sciences and technologies to pharmaceutical and biopharmaceutical engineering;
• Plan, research, execute and oversee a substantial research project, critically analyse and interpret data, and effectively disseminate the results;
• Identify, formulate, analyse and solve problems related to pharmaceutical and biopharmaceutical engineering;
• Design pharmaceutical and biopharmaceutical manufacturing facilities and processes, including unfamiliar, ill-defined scenarios, underpinned by a sustainability informed paradigm, taking account of environmental, health and safety and risk factors, and know how to apply relevant codes of practice, industry standards and emerging practices and technologies;
• Gather experimental data, apply a range of standard and specialized research tools and techniques and conduct critical evaluation of results;
• Reflect and act on social and ethical responsibilities in the practice of engineering, including the responsibilities towards developing sustainable processes and operations;
• Work effectively as an individual and in teams in planning and carrying through on assignments and projects in a lifelong learning context;
• Communicate effectively with the engineering community and with society at large.

Programme Learning Outcomes for Postgraduate Diploma in Pharmaceutical and Biopharmaceutical Engineering (NFQ Level 9, Major Award)
On successful completion of this programme, students should be able to:

• Apply an enhanced knowledge and understanding of the mathematics, sciences, engineering sciences and technologies to pharmaceutical and biopharmaceutical engineering;
• Identify, formulate, analyse and solve problems related to pharmaceutical and biopharmaceutical engineering;
• Design pharmaceutical and biopharmaceutical manufacturing facilities and processes, including unfamiliar, ill-defined scenarios, underpinned by a sustainability informed paradigm, taking account of environmental, health and safety and risk factors, and know how to apply relevant codes of practice, industry standards and emerging practices and technologies;
• Gather experimental data, apply a range of standard and specialized research tools and techniques and conduct critical evaluation of results;
• Reflect and act on social and ethical responsibilities in the practice of engineering, including the responsibilities towards developing sustainable processes and operations;
• Work effectively as an individual and in teams in planning and carrying through on assignments and projects in a lifelong learning context;
• Communicate effectively with the engineering community and with society at large.